Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson’s Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Table 2

Demographic data of 32 PD patients.

	Included ()	Excluded ()
Age, years, median (IQR)	61.5 (9.5)	65.5 (11.5)
Sex, females, n (%)	5 (31)	11 (68)
Duration of disease, years, median (IQR)	13.0 (8.0)	13.5 (4.3)
Duration of medication, years, median (IQR)	11.5 (7.0)	11.0 (4.5)
Hoehn and Yahr stage, median (IQR)	3.0 (1.0)	3.0 (0.3)
Final stimulation setting, median (IQR)
Pulse, microseconds	60.0 (0.00)	60.0 (7.5)
Hz	130.0 (0.0)	130.0 (15.0)
Volts	1.68 (1.21)	2.00 (0.95)
First LEDD	1216 (614)	1281 (473)
Final LEDD	555 (315)	713 (334)
Dominant affected side, right (%)	12 (75)	9 (56)

IQR, interquartile range; LEDD, levodopa equivalent daily dose.